Agilent Q2 Revenues Flat, Matching Analyst Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent said after the close of the market on Wednesday that its Fiscal Year 2014 second quarter revenues were flat year over year, while its Life Sciences and Diagnostic revenues increased 1 percent.

For the three months ended April 30, Agilent reported total revenues of $1.73 billion, unchanged from a year ago and even with the consensus analyst estimate. Orders in the quarter were up to $1.81 billion from $1.69 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.